Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease Does Less Mean More?

被引:1
|
作者
Gue, Ying X. [1 ]
Gorog, Diana A. [2 ,3 ]
Lip, Gregory Y. H. [1 ,4 ]
机构
[1] Univ Liverpool, Liverpool Heart & Chest Hosp, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[2] Univ Hertfordshire, Sch Life & Med Sci, Postgrad Med Sch, Hatfield, Herts, England
[3] Imperial Coll, Fac Med, Natl Heart & Lung Inst, London, England
[4] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
关键词
D O I
10.1001/jamacardio.2022.1572
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:794 / 795
页数:2
相关论文
共 50 条
  • [21] Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting
    Reed, Grant W.
    Cannon, Christopher P.
    CLINICAL CARDIOLOGY, 2013, 36 (10) : 585 - 594
  • [22] Antithrombotic Therapy for Atrial Fibrillation and stable coronary Heart Disease
    Dovjak, Peter
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2019, 52 (08): : 808 - 809
  • [23] The vast majority of patients with coronary artery disease and atrial fibrillation have indications for antithrombotic therapy
    Tkaczyszyn, M.
    Zielonka, A.
    Nowak, W.
    Rekucki, K.
    Soczomski, P.
    Zielinski, M.
    Pociupany, R.
    Banasiak, W.
    Ponikowski, P.
    Jankowska, E. A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 489 - 490
  • [24] Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
    Lee, So-Ryoung
    Jung, Jin-Hyung
    Choi, Eue-Keun
    Lee, Seung-Woo
    Kwon, Soonil
    Park, Ji-Suck
    Kang, Jeehoon
    Han, Kyung-Do
    Park, Kyung Woo
    Oh, Seil
    Lip, Gregory Y. H.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [25] Atrial fibrillation and coronary artery disease: which antithrombotic treatment strategy?
    Lamberts, Morten
    Dewilde, Willem
    Hansen, Morten Lock
    CURRENT OPINION IN CARDIOLOGY, 2014, 29 (06) : 595 - 600
  • [26] Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents
    Paikin, Jeremy S.
    Mehta, Shamir R.
    Eikelboom, John W.
    MEDICAL JOURNAL OF AUSTRALIA, 2010, 192 (09) : 487 - 488
  • [27] Antithrombotic therapy in patients with combined coronary heart disease and atrial fibrillation
    Thompson, Peter L.
    Morton, Allison C.
    PANMINERVA MEDICA, 2016, 58 (01) : 23 - 33
  • [28] OPTIMAL ANTITHROMBOTIC THERAPY FOR ATRIAL FIBRILLATION AND STABLE CORONARY ARTERY DISEASE - A NETWORK META-ANALYSIS
    Gupta, Rahul
    Malik, Aaqib
    Biggs, Ross
    Vadhar, Sagar
    Racharla, Lekha
    Nagahama, Makoto
    Vyas, Apurva
    Patel, Nainesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 153 - 153
  • [29] Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy
    Fanaroff, Alexander C.
    Li, Shuang
    Marquis-Gravel, Guillaume
    Giri, Jay
    Lopes, Renato D.
    Piccini, Jonathan P.
    Wang, Tracy Y.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (12) : E011232
  • [30] Antithrombotic therapy for stable coronary artery disease and atrial fibrillation in patients with and without revascularisation: the AFIRE trial
    Noda, Takashi
    Nochioka, Kotaro
    Kaikita, Koichi
    Akao, Masaharu
    Ako, Junya
    Matoba, Tetsuya
    Nakamura, Masato
    Miyauchi, Katsumi
    Hagiwara, Nobuhisa
    Kimura, Kazuo
    Hirayama, Atsushi
    Matsui, Kunihiko
    Ogawa, Hisao
    Yasuda, Satoshi
    EUROINTERVENTION, 2024, 20 (07) : E425 - E435